drugset / Trial / NCT00143234

Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels

NCT00143234 ↗

Phase 3 Completed 1825 enrolled Viatris Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to measure the effect of the amlodipine/atorvastatin combination pill in reducing both elevated blood pressure and cholesterol levels to levels suggested by guidelines

Timeline

Start
2004-05
Primary completion
—
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine/atorvastatin Unknown — —